Keyphrases
Ischemic Tolerance
100%
Therapeutic Target
100%
Adenosine Kinase
100%
Adenosine
58%
Seizure
25%
Neuroprotective
25%
Ischemia
25%
Ischemic Brain Injury
16%
Neuroprotection
16%
Acute Symptomatic Seizures
16%
RNA Interference
16%
Cell Loss
16%
AIMS™
8%
Stem Cells
8%
Adenosine Metabolism
8%
Endogenous Neuroprotection
8%
Public Health
8%
Rodent Models
8%
Subsequent Injury
8%
New Therapies
8%
Acute Response
8%
Lentiviral
8%
Therapeutic Blockade
8%
Brain Injury
8%
Therapeutic Approaches
8%
Insults
8%
Brain-damaged Patients
8%
Novel Mechanism
8%
Acute Brain Injury
8%
Focal Cerebral Ischemia
8%
Antiepileptic Drugs
8%
Intrastriatal
8%
Neuroscience
Adenosine Kinase
100%
Adenosine
66%
Neuroprotective Agent
25%
Neuroprotection
25%
Ischemia
25%
Cell Loss
16%
Cerebrovascular Accident
16%
Metabolic Pathway
8%
Brain Ischemia
8%
Stem Cell
8%
Brain Injury
8%
Anticonvulsant
8%